Table 1 Direct agglutination test (DAT) results for anti-Leishmania antibodies in various patients groups.
Serial dilution series | |||||||||
|---|---|---|---|---|---|---|---|---|---|
Patient group | ≤ 800 | 1600 | 3200 | 6400 | 12800 | 25600 | 51200 | 102.400 | Total (n) |
1 confirmed AVL | - | - | 1 | - | 4 | 1 | 3 | 7 | 16 |
2 suspected AVL | 22 | - | 3 | 9 | 8 | 15 | 5 | 37 | 99 |
3 confirmed CL | 84 | - | 1 | - | - | - | - | - | 85 |
4 confirmed Chagas' disease | 10 | 2 | - | - | - | - | - | - | 12 |
5 confirmed trypanosomiasis | 5 | - | - | - | - | - | - | - | 5 |
6 confirmed malaria | 5 | - | - | - | - | - | - | - | 5 |
7 confirmed toxoplasmosis | 5 | - | - | - | - | - | - | - | 5 |
8 healthy endemic controls | 19 | - | - | - | - | - | - | - | 19 |
9 healthy non-endemic controls | 5 | - | - | - | - | - | - | - | 5 |